Mengke Xu

936 total citations · 2 hit papers
33 papers, 705 citations indexed

About

Mengke Xu is a scholar working on Biomedical Engineering, Molecular Biology and Immunology. According to data from OpenAlex, Mengke Xu has authored 33 papers receiving a total of 705 indexed citations (citations by other indexed papers that have themselves been cited), including 24 papers in Biomedical Engineering, 15 papers in Molecular Biology and 10 papers in Immunology. Recurrent topics in Mengke Xu's work include Nanoplatforms for cancer theranostics (24 papers), Photodynamic Therapy Research Studies (6 papers) and Click Chemistry and Applications (5 papers). Mengke Xu is often cited by papers focused on Nanoplatforms for cancer theranostics (24 papers), Photodynamic Therapy Research Studies (6 papers) and Click Chemistry and Applications (5 papers). Mengke Xu collaborates with scholars based in Singapore, China and France. Mengke Xu's co-authors include Kanyi Pu, Jingsheng Huang, Cheng Xu, Chi Zhang, Shasha He, Xin Wei, Jiayan Wu, Yuxuan Hu, Penghui Cheng and Jie Yu and has published in prestigious journals such as Journal of the American Chemical Society, Advanced Materials and Angewandte Chemie International Edition.

In The Last Decade

Mengke Xu

32 papers receiving 699 citations

Hit Papers

Dual-Locked Fluorescence Probe for Monitoring the Dynamic... 2025 2026 2025 2025 5 10 15 20

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Mengke Xu Singapore 17 480 263 190 139 114 33 705
Shu‐Cheng Wan China 14 469 1.0× 327 1.2× 383 2.0× 186 1.3× 111 1.0× 23 913
Zhenzhong Zhang China 13 344 0.7× 191 0.7× 106 0.6× 181 1.3× 69 0.6× 21 586
Sanpeng Li China 9 718 1.5× 266 1.0× 284 1.5× 159 1.1× 152 1.3× 13 895
August Culbert United States 8 574 1.2× 121 0.5× 288 1.5× 195 1.4× 162 1.4× 10 767
Lingpu Zhang China 13 373 0.8× 273 1.0× 177 0.9× 161 1.2× 145 1.3× 24 756
Gengjia Chen China 15 343 0.7× 329 1.3× 79 0.4× 157 1.1× 46 0.4× 35 702
Alexander X. Lozano United States 4 478 1.0× 163 0.6× 335 1.8× 95 0.7× 115 1.0× 5 780
Heegon Kim South Korea 9 252 0.5× 140 0.5× 138 0.7× 87 0.6× 90 0.8× 15 454
Mengbin Ding China 16 524 1.1× 158 0.6× 172 0.9× 126 0.9× 95 0.8× 31 670
Yikai Xu China 14 527 1.1× 269 1.0× 263 1.4× 134 1.0× 221 1.9× 24 804

Countries citing papers authored by Mengke Xu

Since Specialization
Citations

This map shows the geographic impact of Mengke Xu's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Mengke Xu with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Mengke Xu more than expected).

Fields of papers citing papers by Mengke Xu

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Mengke Xu. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Mengke Xu. The network helps show where Mengke Xu may publish in the future.

Co-authorship network of co-authors of Mengke Xu

This figure shows the co-authorship network connecting the top 25 collaborators of Mengke Xu. A scholar is included among the top collaborators of Mengke Xu based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Mengke Xu. Mengke Xu is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Cheng, Penghui, Ziling Zeng, Jing Liu, et al.. (2025). Urinary bioorthogonal reporters for the monitoring of the efficacy of chemotherapy for lung cancer and of associated kidney injury. Nature Biomedical Engineering. 9(5). 686–699. 16 indexed citations
2.
Xu, Mengke, et al.. (2025). The shadow of cancer therapeutic resistance: Unveiling the role of S-palmitoylation. Drug Resistance Updates. 82. 101264–101264. 1 indexed citations
3.
Xu, Mengke & Bo Xu. (2025). Protein lipidation in the tumor microenvironment: enzymology, signaling pathways, and therapeutics. Molecular Cancer. 24(1). 138–138. 1 indexed citations
4.
Hu, Yuxuan, Jing Liu, Mengke Xu, & Kanyi Pu. (2025). Dual-Locked Fluorescence Probe for Monitoring the Dynamic Transition of Pulmonary Macrophages. Journal of the American Chemical Society. 147(8). 7148–7157. 20 indexed citations breakdown →
5.
Lin, Yiguang, Jingsheng Huang, Jing Liu, et al.. (2025). Highly Photoreactive Semiconducting Polymers with Cascade Intramolecular Singlet Oxygen and Energy Transfer for Cancer-Specific Afterglow Theranostics. Journal of the American Chemical Society. 147(3). 2597–2606. 7 indexed citations
6.
Yu, Jie, Jiayan Wu, Jingsheng Huang, et al.. (2025). Hypoxia-tolerant polymeric photosensitizer prodrug for cancer photo-immunotherapy. Nature Communications. 16(1). 153–153. 19 indexed citations breakdown →
7.
8.
Zhang, Chi, Jingsheng Huang, Mengke Xu, et al.. (2024). Eosinophil‐Activating Semiconducting Polymer Nanoparticles for Cancer Photo‐Immunotherapy. Angewandte Chemie International Edition. 63(30). e202405358–e202405358. 17 indexed citations
9.
Huang, Jingsheng, Jing Huang, Jiayan Wu, et al.. (2024). Near‐Infrared Chemiluminophore Switches Photodynamic Processes via Protein Complexation for Biomarker‐Activatable Cancer Therapy. Angewandte Chemie International Edition. 64(12). e202421962–e202421962. 10 indexed citations
10.
Xu, Mengke, Yuxuan Hu, Jiayan Wu, Jing Liu, & Kanyi Pu. (2024). Sonodynamic Nano-LYTACs Reverse Tumor Immunosuppressive Microenvironment for Cancer Immunotherapy. Journal of the American Chemical Society. 146(50). 34669–34680. 33 indexed citations
11.
Huang, Jingsheng, Mengke Xu, Penghui Cheng, et al.. (2024). A Tandem‐Locked Chemiluminescent Probe for Imaging of Tumor‐Associated Macrophage Polarization. Angewandte Chemie. 136(21). 4 indexed citations
12.
Wu, Jiayan, et al.. (2024). Exosome‐Inhibiting Polymeric Sonosensitizer for Tumor‐Specific Sonodynamic Immunotherapy. Advanced Materials. 36(25). e2400762–e2400762. 42 indexed citations
13.
He, Shasha, Chi Zhang, Cheng Xu, et al.. (2023). Polymeric STING Pro‐agonists for Tumor‐Specific Sonodynamic Immunotherapy. Angewandte Chemie. 135(32). 7 indexed citations
14.
15.
He, Shasha, Mengke Xu, Chi Zhang, et al.. (2023). A Semiconducting Iron‐Chelating Nano‐immunomodulator for Specific and Sensitized Sono‐metallo‐immunotherapy of Cancer. Angewandte Chemie International Edition. 62(43). e202310178–e202310178. 43 indexed citations
16.
He, Shasha, Chi Zhang, Cheng Xu, et al.. (2023). Polymeric STING Pro‐agonists for Tumor‐Specific Sonodynamic Immunotherapy. Angewandte Chemie International Edition. 62(32). e202307272–e202307272. 65 indexed citations
17.
Xu, Cheng, Jie Yu, Xiaoyu Ning, et al.. (2023). Semiconducting Polymer Nanospherical Nucleic Acid Probe for Transcriptomic Imaging of Cancer Chemo‐Immunotherapy. Advanced Materials. 35(48). e2306739–e2306739. 9 indexed citations
18.
Xu, Zhishan, et al.. (2023). A Half‐Sandwich Ruthenium(II) (N^N) Complex: Inducing Immunogenic Melanoma Cell Death in Vitro and in Vivo. ChemMedChem. 18(16). e202300131–e202300131. 13 indexed citations
19.
Zhang, Chi, Mengke Xu, Ziling Zeng, et al.. (2023). A Polymeric Extracellular Matrix Nanoremodeler for Activatable Cancer Photo‐Immunotherapy. Angewandte Chemie International Edition. 62(12). e202217339–e202217339. 40 indexed citations
20.
Li, Min, Kuan Wang, Mengke Xu, et al.. (2023). Staphylococcus warneri strain XSB102 exacerbates psoriasis and promotes keratinocyte proliferation in imiquimod-induced psoriasis-like dermatitis mice. Archives of Microbiology. 206(1). 3–3. 2 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026